Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Certificate under Regulation 74(5)_March 31, 2023
April 12, 2023
Notice of Closure of Trading Window_March 31, 2023
March 31, 2023
Announcement under Regulation 30 - Update_March 2023
March 3, 2023
Transcript of Earnings conference call-Q1 FY 22-23
February 22, 2023
Investor Presentation_December 31, 2022
February 17, 2023
Investor Call Outcome_December 31, 2022
February 17, 2023
Intimation for Investor Meet_February 17, 2023
February 14, 2023
Newspaper Advertisement_December 31, 2022
February 10, 2023
Outcome of Board Meeting_February 09, 2023
February 9, 2023
Intimation of Board Meeting_February 09, 2023
February 3, 2023
Intimation on demise of Director_February 2023
February 1, 2023
Reconciliation of Share Capital Audit Report_December 31, 2022
January 16, 2023
Certificate under Regulation 74(5)_December 31, 2022
January 12, 2023
Intimation under Regulation 30_January 09, 2023
January 9, 2023
Notice of Closure of Trading Window_December 31, 2022
December 31, 2022
Proceedings of the EGM_December 29, 2022
December 30, 2022
Previous
1
...
Next
13 / 36